PowerShares Dynamic Heathcare Sector Portfolio | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (30)

Latest Posts

About This Stock More About This Stock
5 Undervalued ETFs To Buy For Second Half Of 2022
Article By: Sweta Killa
Tuesday, June 28, 2022 9:58 PM EDT
Five ETFs from different zones of the market that are currently undervalued could generate solid returns in a rising stock market.
In this article: PSCE, FXO, PTH, JETS, XMVM
5 ETFs Jump After Three-Day Rout: Will The Rally Last?
Article By: Sweta Killa
Thursday, September 10, 2020 11:58 AM EDT
Here are the ETFs that were at the forefront of the market rebound on Sep 9 and will continue to do so if market sentiments remain positive.
In this article: PBW, PTH, ARKQ, CNCR, FNGS Also: AZN, AAPL, MSFT, TSLA
Will Novavax ETFs Gain On Coronavirus Vaccine Progress?
Article By: Zacks Investment Research
Saturday, September 5, 2020 5:50 PM EDT
Novavax (NVAX) is a formidable name in the list of companies who are working on a vaccine. The company’s shares have gained 2487.4% this year. Let’s look at ETFs with the highest exposure to Novarax that can gain on the positive development,
In this article: BBH, PTH, IBB, DWAS, GERM
Filtering For ETFs That Outperformed Blended FANMAG Stocks
Article By: Richard Shaw
Tuesday, March 24, 2020 2:20 AM EDT
In a market populated mostly with mediocre opportunities and led by a small number of high performers, we use extensive filtering to attempt to identify lesser-known or lesser-followed securities that also stand out from the crowd.
In this article: PNQI, PTH, EMQQ, IPOS, XLC, ONLN
Best June For Stocks In Decades: 5 Best ETFs
Article By: Sweta Killa
Wednesday, June 19, 2019 10:36 PM EDT
While there have been winners in every corner of the space, several ETFs have easily crushed the market by wide margins. Here are five top-performing ETFs so far this month that will continue to outperform if the current trends continue.
In this article: GNOM, PTH, SGDM, SILJ, XLB

Latest Tweets for $PTH

No tweets yet!